Artificial intelligence (AI) is bringing a new era to healthcare. A large part of its value is the ability to collect and analyze data sets to streamline administrative processes, improve diagnosis accuracy, and optimize treatment regimens.
Now researchers have added antibiotic discovery to that list.
A recent study published in Nature Machine Intelligence by McMaster University and Stanford University researchers introduces SyntheMol, a generative AI model capable of designing new antibiotics to combat drug-resistant bacteria.
Comments are closed.